慢性骨髓单细胞白血病:2024年关于诊断,风险分层和管理的更新
Mrinal M Patnaik1, Ayalew Tefferi1
1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
American journal of hematology
|March 7, 2024
概括
慢性骨髓单细胞白血病 (CMML) 是一种具有单细胞化和转变风险的干细胞疾病. 全基性干细胞移植 (ASCT) 为高风险的CMML患者提供治疗方法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 干细胞生物学 干细胞生物学
背景情况:
- 慢性骨髓单细胞白血病 (CMML) 是一种克隆性造血干细胞疾病,具有重叠的骨髓显样/骨髓增殖特征.
- 这种CMML的特点是突出的单细胞化,并且在3-5年内具有15-20%的白血病转变风险.
研究的目的:
- 概述了对CMML的修订诊断标准.
- 详细介绍CMML突变的遗传情景和预后影响.
- 审查CMML的风险分层模型和治疗策略.
主要方法:
- 基于持续的外周血液单细胞化,骨髓形态,爆破计数和克隆性证据的诊断.
- 识别体质突变,包括TET2,SRSF2,ASXL1和RAS路径突变.
- 应用风险模型,如梅奥分子模型 (MMM) 患者分层.
主要成果:
- 修订后的标准强调了持续的单细胞化,特定的爆破百分比和克隆性.
- 缺少TET2的ASXL1和DNMT3A突变与较差的生存率有关.
- 异构干细胞移植 (ASCT) 是每MMM高/中等-2风险CMML的唯一治疗选择.
- 像基urea和decitabine这样的药物疗法在高风险的MP-CMML中显示出类似的整体存活率,尽管decitabine的响应率更高.
结论:
- 准确的诊断和风险分层对于指导CMML治疗决策至关重要.
- ASCT仍然是高风险CMML的最终治疗方法.
- 需要进一步的研究来确定CMML的疾病修饰疗法.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.3K
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
87
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...